Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    5.00 (0.86%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.16m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading Update

19 May 2016 07:00

RNS Number : 6525Y
Science Group PLC
19 May 2016
 

 

19 May 2016

 

 

Science Group plc

(the "Company")

 

 

Trading update

 

Science Group plc provides the following update ahead of the Company's Annual General Meeting this morning.

 

Overall the Group performance in the first 4 months of the year is in line with the Board's expectations. At 30 April 2016, the Group had gross cash of £18.4 million and net funds of £10.9 million.

 

As a science-based services business with limited forward visibility, the Group has seen the benefits from the increase in diversification of client end-markets derived from the acquisition programme. In Q1, the Oil & Gas market continued to be challenging and the Medical business continued to suffer from the lack of new projects to replace those completed in 2015. However, following a change in Group management structure and US sales leadership, a number of significant projects have been won in the Medical sector in recent months which should improve performance in this business for the remainder of the year. The Group's other three business areas have performed satisfactorily, with Leatherhead (food & beverage) outperforming the Board's expectations in terms of profit contribution. As a result, in aggregate, Group revenue and adjusted operating profit to date are in line with the Board's expectations.

 

With a significant proportion of the Group's revenue denominated in US Dollars or Euros, there is an inherent sensitivity within the financial results related to foreign currency exchange fluctuations. While this effect impacts most international companies, IFRS accounting results in Science Group being particularly susceptible due to the majority of the Group's non-Sterling denominated invoices being raised directly from the UK. In brief, IFRS accounting requires that in this operating model, the balance sheet (debtor and WIP) of the relevant operating UK subsidiary is revalued each month with any positive or negative movement being recognised in the Group P&L; in the case where the non-Sterling revenues are invoiced from an in-country subsidiary, such variances would be recognised directly in reserves, although in pre-tax cash terms there is no material difference. This accounting anomaly results in significant additional FX volatility in the reported IFRS Group P&L statement but has the cash benefit of recording profits in the UK (where the work is undertaken) with its lower corporation tax rate. The recent volatility in Sterling-US Dollar exchange rates has brought this issue into sharp focus but the Board considers that the cash benefit to the Group outweighs the non-cash IFRS P&L reporting volatility.

 

The works at Great Burgh, Epsom have now received planning consent and, despite the delays in this process, relocation of the Leatherhead and OTM businesses remains on track to be completed over the summer. Approximately 80 employees are now based at Epsom and feedback from client events held there in recent weeks has been excellent. Following the purchase of the Great Burgh freehold property, the Board has now commenced negotiations regarding the possibility of increasing the Group's banking facilities, such debt to be secured on the Group's substantial freehold property assets which had a carrying value of £20.9 million as at 31 December 2015.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Hemsted, Finance Director

 

Numis Securities Limited

Nominated Adviser: Simon Willis / Paul Gillam

Tel: +44 (0) 20 7260 1000

Corporate Broking: Michael Burke

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWVVRNRAVAAR
Date   Source Headline
27th Mar 20259:21 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSExecutive Chair Share Purchase
26th Mar 20257:00 amRNSExecutive Chair Share Purchase
25th Mar 20252:20 pmRNSDirector Dealing
24th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSNotice of Preliminary Results
19th Mar 202512:33 pmRNSHolding(s) in Company
19th Mar 20257:01 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSBank Refinancing & Ricardo Strategic Investment
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:01 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSResponse to Ricardo plc
14th Mar 20253:15 pmRNSResponse to Science Group plc
14th Mar 202510:38 amRNSHolding(s) in Company
14th Mar 20257:01 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSIncreased Shareholding in Ricardo plc
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 202510:54 amRNSHolding(s) in Company
11th Mar 20258:29 amRNSShareholding in Ricardo plc
10th Mar 20252:19 pmRNSHolding(s) in Company
10th Mar 20251:42 pmRNSIncreased Shareholding in Ricardo plc
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20253:31 pmRNSHolding(s) in Company
3rd Mar 20253:30 pmRNSHolding(s) in Company
3rd Mar 202510:05 amRNSIncreased Shareholding in Ricardo plc
28th Feb 20257:01 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSStrategic Investment in Ricardo plc
27th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:01 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSFY24 Trading Update & 2025 Buy-Back Programme
2nd Jan 20257:00 amRNSTotal Voting Rights
20th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.